Last reviewed · How we verify
KL590586 Capsule — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
KL590586 Capsule (KL590586 Capsule) — Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| KL590586 Capsule TARGET | KL590586 Capsule | Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- KL590586 Capsule CI watch — RSS
- KL590586 Capsule CI watch — Atom
- KL590586 Capsule CI watch — JSON
- KL590586 Capsule alone — RSS
Cite this brief
Drug Landscape (2026). KL590586 Capsule — Competitive Intelligence Brief. https://druglandscape.com/ci/kl590586-capsule. Accessed 2026-05-14.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab